Efgartigimod alfa/hyaluronidase Interactions
There are 382 drugs known to interact with efgartigimod alfa/hyaluronidase, along with 2 disease interactions. Of the total drug interactions, 45 are major, 246 are moderate, and 91 are minor.
Medications known to interact with efgartigimod alfa/hyaluronidase
Note: Showing generic names only.
- abatacept
- abciximab
- abrocitinib
- acrivastine
- adalimumab
- adenovirus vaccine
- ado-trastuzumab emtansine
- aducanumab
- alefacept
- alemtuzumab
- alirocumab
- allogeneic processed thymus tissue
- aminosalicylic acid
- amivantamab
- anakinra
- anifrolumab
- anthrax vaccine adsorbed
- anti-thymocyte globulin (rabbit)
- antihemophilic factor
- asfotase alfa
- ashwaganda
- aspirin
- astemizole
- atezolizumab
- avelumab
- axatilimab
- azatadine
- azathioprine
- balsalazide
- bamlanivimab
- baricitinib
- basiliximab
- bcg
- bcg vaccine
- bebtelovimab
- belantamab mafodotin
- belatacept
- belimumab
- benralizumab
- betamethasone
- bevacizumab
- bevacizumab ophthalmic
- bezlotoxumab
- bifidobacterium infantis
- bifidobacterium longum
- bimekizumab
- bismuth subsalicylate
- blinatumomab
- botulism immune globulin
- brentuximab
- brewer's yeast
- brodalumab
- brompheniramine
- budesonide
- bupivacaine
- bupivacaine liposome
- burosumab
- canakinumab
- candida albicans extract
- caplacizumab
- carbinoxamine
- cat's claw
- cemiplimab
- certolizumab
- cetirizine
- cetuximab
- chikungunya vaccine, live (cvx 317)
- chikungunya vaccine, recombinant (cvx 329)
- chlorcyclizine
- chloroprocaine
- chlorotrianisene
- chlorpheniramine
- cholera vaccine
- cholera vaccine, live
- choline salicylate
- cladribine
- clemastine
- coagulation factor ix
- coccidioidin skin test
- concizumab
- conjugated estrogens
- conjugated estrogens topical
- corticorelin
- corticotropin
- cortisone
- cosibelimab
- cosyntropin
- COVID-19 mRNA (Moderna) vaccine
- COVID-19 mRNA (Pfizer) vaccine
- crizanlizumab
- cyclizine
- cyproheptadine
- cytomegalovirus immune globulin
- daclizumab
- daratumumab
- datopotamab deruxtecan
- dengue vaccine
- denosumab
- desloratadine
- deucravacitinib
- dexamethasone
- dexbrompheniramine
- dexchlorpheniramine
- dienestrol topical
- diethylstilbestrol
- diflunisal
- dimethyl fumarate
- dinutuximab
- diphenhydramine
- diroximel fumarate
- donanemab
- dopamine
- dostarlimab
- doxylamine
- dulaglutide
- dupilumab
- durvalumab
- echinacea
- eculizumab
- efalizumab
- efbemalenograstim alfa
- elderberry
- elotuzumab
- elranatamab
- emapalumab
- emicizumab
- enfortumab vedotin
- ephedrine
- epinephrine
- eptinezumab
- erenumab
- esterified estrogens
- estradiol
- estradiol topical
- estramustine
- estrone
- estropipate
- estropipate topical
- etanercept
- ethinyl estradiol
- etidocaine
- etrasimod
- evinacumab
- evolocumab
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b immune globulin
- hepatitis b pediatric vaccine
- histoplasmin
- human papillomavirus vaccine
- hydrocortisone
- hydroxyzine
- ibalizumab
- ibritumomab
- idarucizumab
- immune globulin intramuscular
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- immune globulin subcutaneous
- inebilizumab
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- inotuzumab ozogamicin
- iodine i 131 tositumomab
- ipilimumab
- isatuximab
- ixekizumab
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- lanadelumab
- lebrikizumab
- lecanemab
- leflunomide
- levobupivacaine
- levocetirizine
- lidocaine
- loncastuximab tesirine
- loratadine
- luspatercept
- lyme disease vaccine
- lymphocyte immune globulin, anti-thy (equine)
- magnesium salicylate
- margetuximab
- marstacimab
- measles virus vaccine
- meclizine
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- mepivacaine
- mepolizumab
- mesalamine
- metaraminol
- methdilazine
- methylprednisolone
- mirikizumab
- mixed respiratory vaccine
- mogamulizumab
- monomethyl fumarate
- mumps skin test antigen
- mumps virus vaccine
- muromonab-cd3
- nadofaragene firadenovec
- natalizumab
- naxitamab
- necitumumab
- nemolizumab
- niraparib
- nirsevimab
- nivolumab
- norepinephrine
- palivizumab
- panitumumab
- pembrolizumab
- pemivibart
- pertussis, acellular
- pertuzumab
- phenindamine
- phenylephrine
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- polatuzumab vedotin
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- ponesimod
- pozelimab
- prednisolone
- prednisone
- prilocaine
- procaine
- promethazine
- propiomazine
- pyrilamine
- rabies immune globulin, human
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- ramucirumab
- ravulizumab
- reslizumab
- respiratory syncytial virus immune globulin
- retifanlimab
- rho (d) immune globulin
- rilonacept
- risankizumab
- ritlecitinib
- rituximab
- roflumilast
- romiplostim
- romosozumab
- ropivacaine
- rotavirus vaccine
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
- saccharomyces boulardii lyo
- sacituzumab govitecan
- salsalate
- sarilumab
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- satralizumab
- secukinumab
- siltuximab
- siponimod
- sipuleucel-T
- skin test antigens, multiple
- smallpox and mpox vaccine
- smallpox vaccine
- sodium salicylate
- sodium thiosalicylate
- sotatercept
- sotrovimab
- spesolimab
- staphage lysate (spl)
- streptococcus salivarius
- sulfasalazine
- tafasitamab
- talimogene laherparepvec
- talquetamab
- tarlatamab
- teclistamab
- teprotumumab
- terfenadine
- teriflunomide
- tetanus immune globulin
- tetanus toxoid
- tetracaine
- tezepelumab
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tildrakizumab
- tislelizumab
- tisotumab vedotin
- tocilizumab
- tofacitinib
- toripalimab
- tositumomab
- tralokinumab
- trastuzumab
- tremelimumab
- triamcinolone
- trichophyton skin test
- trimeprazine
- tripelennamine
- triprolidine
- tuberculin purified protein derivative
- typhoid vaccine, inactivated
- typhoid vaccine, live
- vaccinia immune globulin
- vamorolone
- varicella virus vaccine
- varicella zoster immune globulin
- vedolizumab
- vilobelimab
- vitamin e
- voclosporin
- zanidatamab
- zenocutuzumab
- zinc acetate
- zinc chloride
- zinc gluconate
- zinc sulfate
- ziv-aflibercept
- zolbetuximab
- zoster vaccine live
- zoster vaccine, recombinant
Efgartigimod alfa/hyaluronidase disease interactions
There are 2 disease interactions with efgartigimod alfa / hyaluronidase which include:
More about efgartigimod alfa / hyaluronidase
- efgartigimod alfa/hyaluronidase consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: immune globulins
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Soliris
Soliris infusion is used to treat paroxysmal nocturnal hemoglobinuria (PNH) or neuromyelitis optica ...
Vyvgart Hytrulo
Vyvgart Hytrulo is used to treat generalized myasthenia gravis (gMG) or chronic inflammatory ...
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Zilbrysq
Zilbrysq (zilucoplan) is a C5 inhibitor used to treat generalized myasthenia gravis (gMG) in AChR ...
Rystiggo
Rystiggo is used to treat generalized myasthenia gravis (gMG) in adults who are acetylcholine ...
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Hizentra
Hizentra (immune globulin) is used as a replacement therapy in patients with primary humoral ...
Mestinon
Mestinon (pyridostigmine) is used to increase muscle strength in conditions such as myasthenia ...
Neostigmine
Neostigmine systemic is used for myasthenia gravis, reversal of neuromuscular blockade, reversal of ...
Pyridostigmine
Pyridostigmine systemic is used for dysautonomia, myasthenia gravis, nerve agent pretreatment ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.